Topoisomerase II (TOP2)

Assets acting on this target.

Class
Topoisomerase II inhibitor (anthracenedione antineoplastic)
Notes
verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT07490288

Related mechanisms

← all mechanisms